Drugmakers to Multiple Sclerosis Group: Shut Up About Prices, or Else

by Admin | September 28, 2016 11:48 am

September 28, 2016—The New York Times published a shocking article this morning about how drug companies tried to strong-arm a patient-advocacy group to keep quiet about obscenely high drug prices. As we’ve noted before, stories like these raise questions about what’s motivating some disease-awareness groups to bad-mouth the 340B drug discount program[1].

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2]. Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:

340B drug discount program: https://www.youtube.com/watch?v=_OnL4ueIPXU
Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2016/09/drugmakers-to-multiple-sclerosis-group-shut-up-about-prices-or-else/